iohexol has been researched along with Mastocytosis in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the mechanism of anaphylactoid reactions to contrast media, in vitro histamine release induced by magnetic resonance imaging, and iodinated contrast agents was examined in a dog mastocytoma cell line." | 1.29 | In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. ( Baxter, AB; Brasch, RC; Lazarus, SC, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxter, AB | 1 |
| Lazarus, SC | 1 |
| Brasch, RC | 1 |
1 other study available for iohexol and Mastocytosis
| Article | Year |
|---|---|
In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
Topics: Anaphylaxis; Animals; Cell Line; Contrast Media; Diatrizoate Meglumine; Dogs; Gadolinium; Gadolinium | 1993 |